Abstract

BackgroundThe Drug Ontology (DrOn) is a modular, extensible ontology of drug products, their ingredients, and their biological activity created to enable comparative effectiveness and health services researchers to query National Drug Codes (NDCs) that represent products by ingredient, by molecular disposition, by therapeutic disposition, and by physiological effect (e.g., diuretic). It is based on the RxNorm drug terminology maintained by the U.S. National Library of Medicine, and on the Chemical Entities of Biological Interest ontology. Both national drug codes (NDCs) and RxNorm unique concept identifiers (RXCUIS) can undergo changes over time that can obfuscate their meaning when these identifiers occur in historic data. We present a new approach to modeling these entities within DrOn that will allow users of DrOn working with historic prescription data to more easily and correctly interpret that data.ResultsWe have implemented a full accounting of national drug codes and RxNorm unique concept identifiers as information content entities, and of the processes involved in managing their creation and changes. This includes an OWL file that implements and defines the classes necessary to model these entities. A separate file contains an instance-level prototype in OWL that demonstrates the feasibility of this approach to representing NDCs and RXCUIs and the processes of managing them by retrieving and representing several individual NDCs, both active and inactive, and the RXCUIs to which they are connected. We also demonstrate how historic information about these identifiers in DrOn can be easily retrieved using a simple SPARQL query.ConclusionsAn accurate model of how these identifiers operate in reality is a valuable addition to DrOn that enhances its usefulness as a knowledge management resource for working with historic data.

Highlights

  • The Drug Ontology (DrOn) is a modular, extensible ontology of drug products, their ingredients, and their biological activity created to enable comparative effectiveness and health services researchers to query National Drug Codes (NDCs) that represent products by ingredient, by molecular disposition, by therapeutic disposition, and by physiological effect

  • We have built an Web Ontology Language (OWL) prototype that demonstrates the feasibility of this approach to representing NDCs and RxNorm Concept Unique Identifier (RXCUI) and the processes of managing them by retrieving data for several NDCs, both active and inactive, and the RXCUIs to which they are connected, and representing these instances as individuals in OWL

  • We have demonstrated that when this OWL representation is loaded into a triple store database for query and manipulation, historic information about drug identifiers can be retrieved using a SPARQL Protocol and RDF Query Language (SPARQL) query

Read more

Summary

Introduction

The Drug Ontology (DrOn) is a modular, extensible ontology of drug products, their ingredients, and their biological activity created to enable comparative effectiveness and health services researchers to query National Drug Codes (NDCs) that represent products by ingredient, by molecular disposition, by therapeutic disposition, and by physiological effect (e.g., diuretic) It is based on the RxNorm drug terminology maintained by the U.S National Library of Medicine, and on the Chemical Entities of Biological Interest ontology. It was created to enable comparative effectiveness and health services researchers to query National Drug Codes (NDCs) [5] that represent products by ingredient, by molecular disposition (e.g., beta-adrenergic receptor molecule blockade), by therapeutic disposition (e.g., antihypertensive), and by physiological effect (e.g., diuretic) It is based on the RxNorm [6] drug terminology maintained by the U.S National Library of Medicine (NLM), and on Chemical Entities of Biological Interest (ChEBI) [7]. This comprehensive modeling of NDCs and RXCUIs as ICEs, as well as of the entities and processes involved in managing these identifiers, improves DrOn’s representation by bringing it into close correspondence with reality

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.